Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Day One Biopharmaceuticals (DAWN) Return on Sales: 2025

Historic Return on Sales for Day One Biopharmaceuticals (DAWN) over the last 1 years, with Sep 2025 value amounting to -1.13%.

  • Day One Biopharmaceuticals' Return on Sales was N/A to -1.13% in Q3 2025 from the same period last year, while for Sep 2025 it was -1.13%, marking a year-over-year change of. This contributed to the annual value of -1.56% for FY2024, which is N/A change from last year.
  • Day One Biopharmaceuticals' Return on Sales amounted to -1.13% in Q3 2025, which was down 121.44% from -0.51% recorded in Q2 2025.
  • In the past 5 years, Day One Biopharmaceuticals' Return on Sales ranged from a high of -0.51% in Q2 2025 and a low of -1.13% during Q3 2025.
  • Its 1-year average for Return on Sales is -0.92%, with a median of -1.10% in 2025.